Cost-utility of tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis in France: a multi-state Markov model analysis.
Saved in:
| Title: | Cost-utility of tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis in France: a multi-state Markov model analysis. |
|---|---|
| Authors: | Fournier J; Department of Epidemiology and Medical Evaluation, CHU Grenoble Alpes, Grenoble, France. jfournier@chu-grenoble.fr., Boussat B; Department of Epidemiology and Medical Evaluation, CHU Grenoble Alpes, Grenoble, and Laboratory TIMC, UMR 5525, CNRS, Joseph Fourier University, Grenoble, France., Dervaux B; Department of Research and Innovation, CHRU Lille, Lille, France., Gaudin P; T-RAIG, TIMC, UMR 5525 CNRS, University of Grenoble Alpes, CHU Grenoble Alpes, Grenoble, and Department of Rheumatology, CHU Grenoble Alpes, Grenoble, France., Romand X; T-RAIG, TIMC, UMR 5525 CNRS, University of Grenoble Alpes, CHU Grenoble Alpes, Grenoble, and Department of Rheumatology, CHU Grenoble Alpes, Grenoble, France. |
| Source: | Clinical and experimental rheumatology [Clin Exp Rheumatol] 2025 Jan; Vol. 43 (1), pp. 62-69. Date of Electronic Publication: 2024 Oct 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Clinical And Experimental Rheumatology S.A.S Country of Publication: Italy NLM ID: 8308521 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0392-856X (Print) Linking ISSN: 0392856X NLM ISO Abbreviation: Clin Exp Rheumatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39360378 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cost-utility of tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis in France: a multi-state Markov model analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fournier+J%22">Fournier J</searchLink>; Department of Epidemiology and Medical Evaluation, CHU Grenoble Alpes, Grenoble, France. jfournier@chu-grenoble.fr.<br /><searchLink fieldCode="AU" term="%22Boussat+B%22">Boussat B</searchLink>; Department of Epidemiology and Medical Evaluation, CHU Grenoble Alpes, Grenoble, and Laboratory TIMC, UMR 5525, CNRS, Joseph Fourier University, Grenoble, France.<br /><searchLink fieldCode="AU" term="%22Dervaux+B%22">Dervaux B</searchLink>; Department of Research and Innovation, CHRU Lille, Lille, France.<br /><searchLink fieldCode="AU" term="%22Gaudin+P%22">Gaudin P</searchLink>; T-RAIG, TIMC, UMR 5525 CNRS, University of Grenoble Alpes, CHU Grenoble Alpes, Grenoble, and Department of Rheumatology, CHU Grenoble Alpes, Grenoble, France.<br /><searchLink fieldCode="AU" term="%22Romand+X%22">Romand X</searchLink>; T-RAIG, TIMC, UMR 5525 CNRS, University of Grenoble Alpes, CHU Grenoble Alpes, Grenoble, and Department of Rheumatology, CHU Grenoble Alpes, Grenoble, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228308521%22">Clinical and experimental rheumatology</searchLink> [Clin Exp Rheumatol] 2025 Jan; Vol. 43 (1), pp. 62-69. <i>Date of Electronic Publication: </i>2024 Oct 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Clinical+And+Experimental+Rheumatology+S%2EA%2ES%22">Clinical And Experimental Rheumatology S.A.S </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>8308521 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>0392-856X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220392856X%22">0392856X </searchLink><i>NLM ISO Abbreviation: </i>Clin Exp Rheumatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39360378 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.55563/clinexprheumatol/3f60yv Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 62 Titles: – TitleFull: Cost-utility of tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis in France: a multi-state Markov model analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fournier J – PersonEntity: Name: NameFull: Boussat B – PersonEntity: Name: NameFull: Dervaux B – PersonEntity: Name: NameFull: Gaudin P – PersonEntity: Name: NameFull: Romand X IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2025 Jan Type: published Y: 2025 Identifiers: – Type: issn-print Value: 0392-856X Numbering: – Type: volume Value: 43 – Type: issue Value: 1 Titles: – TitleFull: Clinical and experimental rheumatology Type: main |
| ResultId | 1 |